적색광 치료 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 기기 카테고리별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Red Light Therapy Market Summary

The global red light therapy market size was estimated at USD 533.8 million in 2025 and is projected to reach USD 1,133.1 million by 2033, growing at a CAGR of 9.8% from 2026 to 2033. The industry has gained significant traction in recent years as consumers and healthcare providers increasingly adopt non-invasive and technology-driven treatment options for skin care, pain management, and overall wellness.

Red light therapy, also known as photobiomodulation, uses wavelengths of red or near-infrared light to stimulate cellular activity and enhance tissue repair. The therapy works by penetrating the skin and stimulating mitochondrial activity, thereby increasing cellular energy production and supporting processes such as collagen synthesis, tissue regeneration, and inflammation reduction. These biological effects have led to the widespread use of RLT in dermatology, sports recovery, rehabilitation, and aesthetic medicine.

Another key factor driving the demand for RLT devices is the growing consumer preference for non-invasive aesthetic treatments. Many individuals are increasingly seeking alternatives to surgical procedures for acne management, skin rejuvenation, and anti-aging. Red light therapy is widely promoted for reducing wrinkles, improving skin texture, and stimulating collagen production. This demand has expanded the availability of light-based treatment devices across dermatology clinics, medi-spas, and wellness centers. At the same time, the rapid growth of at-home beauty technology has made RLT more accessible, with facial masks, handheld devices, and full-body panels becoming widely available to consumers.

The rise of digital wellness culture and social media influence has further accelerated the adoption of red light therapy products. Platforms such as TikTok and Instagram have played a key role in spreading awareness about RLT devices through influencers and celebrity endorsements. For instance, in March 2025, a report by Allure Magazine highlighted the rapid rise in consumer interest in red light therapy devices, particularly LED facial masks, fueled by viral social media trends and celebrity endorsements. The publication noted that content related to red light therapy has generated over 70 million views on TikTok, reflecting strong consumer awareness and demand for at-home phototherapy devices. This reflects strong consumer curiosity and awareness about the technology.

Moreover, the growing prevalence of skin disorders, chronic pain, and inflammatory conditions further supports the expansion of the market. Red light therapy is increasingly used as a supportive treatment for conditions such as acne, eczema, psoriasis, and musculoskeletal pain due to its anti-inflammatory and tissue-healing properties. According to the article published by The Conversation in January 2025, clinical research shows red light therapy can help reduce pain, inflammation, and tissue damage in certain medical conditions. The article highlighted that randomized controlled trials have demonstrated benefits in musculoskeletal pain, wound healing, and treatment-related inflammation, although experts noted that some broader claims about the therapy still require stronger clinical evidence. Health professionals and physiotherapy clinics are incorporating light-based therapies into treatment protocols for rehabilitation and sports recovery. This shift toward light-based therapeutic solutions reflects a broader trend toward drug-free and minimally invasive treatment approaches in modern healthcare.

The growth is also attributed to the growing popularity of wellness and recovery technologies among athletes and fitness enthusiasts. Red light therapy panels and beds are increasingly used in sports medicine facilities to support muscle recovery, reduce inflammation, and improve circulation after intense physical activity. The growing number of sports injuries and the rising emphasis on recovery-focused fitness routines have encouraged gyms, physiotherapy centers, and wellness studios to integrate these systems into their services.

Technological advancements are further supporting the development of the red light therapy industry. Manufacturers are introducing multi-wavelength devices, portable systems, and smart devices integrated with mobile applications that allow users to personalize treatment sessions and monitor progress. These innovations are expanding the use of RLT beyond clinics into home-based healthcare and consumer wellness applications. As awareness of photobiomodulation continues to grow and device technologies improve, red light therapy is increasingly being positioned as a holistic wellness tool that combines aesthetics, recovery, and preventive health benefits, which is expected to sustain the demand for RLT products in the coming years.

Global Red Light Therapy Market Report Segmentation

This report forecasts revenue growth at global levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global red light therapy market report based on product, application, device category, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Face Mask
• Hair Cap/Hair Helmets
• Wands
• Panels
• Beds/Pods
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Muscle Recovery & Medical applications
• Cosmetic
  • Skin Health
  • Hair health
• Device Category Outlook (Revenue, USD Million, 2021 - 2033)
• Premium
• Budget-friendly
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• B2B
• B2C
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Device Category
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. Device Category outlook
  • 2.2.4. End Use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Red Light Therapy (RLT) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Red Light Therapy (RLT) Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Red Light Therapy (RLT) Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Red Light Therapy (RLT) Market: Product Movement Analysis
• 4.3. Red Light Therapy (RLT) Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Face Mask
  • 4.5.1. Face Mask Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hair Cap/Hair Helmets
  • 4.6.1. Hair Cap/Hair Helmets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Wands
  • 4.7.1. Wands Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Panels
  • 4.8.1. Panels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Beds/Pods
  • 4.9.1. Beds/Pods Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Others
  • 4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Red Light Therapy (RLT) Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Red Light Therapy (RLT) Market: Application Movement Analysis
• 5.3. Red Light Therapy (RLT) Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Muscle recovery & Medical applications
  • 5.5.1. Muscle Recovery & Medical Applications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Cosmetic
  • 5.6.1. Cosmetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Skin Health
    • 5.6.2.1. Skin Health Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Hair health
    • 5.6.3.1. Hair Health Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Red Light Therapy (RLT) Market: Device Category Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Red Light Therapy (RLT) Market: Device Category Movement Analysis
• 6.3. Red Light Therapy (RLT) Market by Device Category Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Premium
  • 6.5.1. Premium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Budget-friendly
  • 6.6.1. Budget-friendly Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Red Light Therapy (RLT) Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Red Light Therapy (RLT) Market: End Use Movement Analysis
• 7.3. Red Light Therapy (RLT) Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. B2B
  • 7.5.1. B2B Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. B2C
  • 7.6.1. B2C Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Red Light Therapy (RLT) Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Regional Red Light Therapy (RLT) Market Movement Analysis
• 8.3. Red Light Therapy (RLT) Market: Regional Estimates & Trend Analysis by Modality & End-use
• 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.6. Denmark
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6.8. Norway
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Mito Red Light
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Product Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. LightStim
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Product Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. Joovv, Inc.
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Product Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. Therabody
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Product Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Currentbody
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Product Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. NovoTHOR
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Product Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. TheraLight
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Product Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. EZ-Therapylight
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Product Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. Sunglor
    • 9.2.9.1. Company Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Product Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. Omnilux
    • 9.2.10.1. Company Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Product Benchmarking
    • 9.2.10.4. Strategic Initiatives
  • 9.2.11. Solawave
    • 9.2.11.1. Company Overview
    • 9.2.11.2. Financial Performance
    • 9.2.11.3. Product Benchmarking
    • 9.2.11.4. Strategic Initiatives
  • 9.2.12. Medicube
    • 9.2.12.1. Company Overview
    • 9.2.12.2. Financial Performance
    • 9.2.12.3. Product Benchmarking
    • 9.2.12.4. Strategic Initiatives